Key Insights
The North American self-monitoring blood glucose (SMBG) market, valued at approximately $8.1 billion in 2025, is projected to experience robust growth, driven by the escalating prevalence of diabetes and related complications. The market's Compound Annual Growth Rate (CAGR) of 6.98% from 2019 to 2024 suggests a continuously expanding demand for SMBG devices. This growth is fueled by an aging population, increasing sedentary lifestyles contributing to type 2 diabetes, and growing awareness of proactive diabetes management. Technological advancements, such as the development of more accurate, user-friendly, and minimally invasive devices, coupled with rising healthcare expenditure in the region, further contribute to market expansion. The segment encompassing self-monitoring blood glucose devices by component (e.g., test strips, lancets, meters) demonstrates significant potential, with the demand for advanced integrated systems likely driving future growth. Competition among key players, including Medisana, Rossmax, Trivida, LifeScan, Acon, Agamatrix, Roche, Abbott, Bionime, Arkray, and Ascensia, is expected to remain intense, prompting innovation and pricing strategies to maintain market share.
The North American market is segmented geographically, with the United States holding the largest share due to a high prevalence of diabetes, extensive healthcare infrastructure, and high disposable income. Canada and Mexico also contribute significantly, although at lower rates compared to the US, influenced by factors such as healthcare accessibility and affordability. While increasing awareness and improved healthcare infrastructure are positive drivers, challenges such as the high cost of SMBG devices and the potential for inaccuracies with certain technologies pose restraints. Future growth will be influenced by the regulatory environment, technological innovations, and the integration of SMBG devices into broader diabetes management programs, including remote monitoring and telehealth initiatives. The market is anticipated to show consistent expansion, reflecting continued demand and advancements in technology across the coming years.
North America Self-Monitoring Blood Glucose Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the North America self-monitoring blood glucose (SMBG) market, encompassing the parent market of diabetes care and the child market of SMBG devices. The study covers the period from 2019 to 2033, with a focus on the forecast period 2025-2033, base year 2025, and estimated year 2025. This report is crucial for industry professionals seeking to understand market dynamics, growth trends, and key players shaping this vital sector. The market is segmented by Self-monitoring Blood Glucose Devices: By Component, providing granular insights into specific areas of growth. The projected market size (in million units) is available throughout the report for different time periods.

North America Self-monitoring Blood Glucose Market Market Dynamics & Structure
The North American SMBG market is characterized by moderate concentration, with several key players dominating the landscape. Technological innovation, particularly in areas like connected devices and data analytics, is a primary growth driver. Stringent regulatory frameworks govern the market, ensuring product safety and efficacy. Competitive substitutes, such as continuous glucose monitoring (CGM) systems, present both challenges and opportunities. The end-user demographic primarily comprises individuals with diabetes, with a growing focus on improving accessibility and user experience. M&A activity has been significant in recent years, driving consolidation and innovation.
- Market Concentration: xx% market share held by top 5 players in 2024.
- Technological Innovation: Focus on connected devices, AI-driven analytics, and improved accuracy.
- Regulatory Framework: Stringent FDA approvals and guidelines impact market entry and product features.
- Competitive Substitutes: Increasing CGM adoption challenges SMBG market growth.
- End-User Demographics: Aging population and rising diabetes prevalence are key factors.
- M&A Trends: xx major M&A deals observed between 2019 and 2024.
North America Self-monitoring Blood Glucose Market Growth Trends & Insights
The North American SMBG market experienced a CAGR of xx% during 2019-2024, driven by rising diabetes prevalence and increased awareness of blood glucose management. Adoption rates have increased steadily, albeit with variations across different regions and demographics. Technological disruptions, such as the introduction of connected devices, have significantly impacted market dynamics. Consumer behavior is shifting towards user-friendly devices with advanced features and data integration capabilities. The market is expected to witness a CAGR of xx% during the forecast period (2025-2033), reaching xx million units by 2033. Market penetration is expected to increase further, particularly in underserved populations.

Dominant Regions, Countries, or Segments in North America Self-monitoring Blood Glucose Market
The United States currently holds the largest market share within North America, driven by factors such as high diabetes prevalence, strong healthcare infrastructure, and increased access to advanced technologies. Within the SMBG device segment, the lancets and test strips component represents a significant portion of the market due to high consumption rates.
- Key Drivers in the US: High diabetes prevalence, advanced healthcare infrastructure, and strong government initiatives.
- Dominance Factors: Large patient population, high healthcare expenditure, and readily available testing supplies.
- Growth Potential: Expanding access to diabetes care in underserved communities.
- Market Share: The US holds approximately xx% of the North American SMBG market.
North America Self-monitoring Blood Glucose Market Product Landscape
The SMBG market offers a range of products, from basic blood glucose meters to advanced connected devices with mobile app integration. Key features include ease of use, accuracy, connectivity, and data management capabilities. Recent innovations focus on improving accuracy, reducing lancet pain, and providing seamless data integration for better diabetes management. Many companies are emphasizing features like smaller device size, longer battery life and improved data visualization.
Key Drivers, Barriers & Challenges in North America Self-monitoring Blood Glucose Market
Key Drivers:
- Rising prevalence of diabetes.
- Increased awareness of blood glucose management.
- Technological advancements leading to improved accuracy and convenience.
- Government initiatives and insurance coverage for diabetes care.
Challenges & Restraints:
- High cost of SMBG devices and consumables.
- Competition from CGM systems.
- Supply chain disruptions impacting availability of testing supplies.
- Regulatory hurdles associated with device approval and market access.
Emerging Opportunities in North America Self-monitoring Blood Glucose Market
- Integration of SMBG data with other health monitoring devices.
- Development of personalized diabetes management solutions.
- Expansion into underserved markets with limited access to diabetes care.
- Leveraging telemedicine and remote patient monitoring for improved care.
Growth Accelerators in the North America Self-monitoring Blood Glucose Market Industry
Technological breakthroughs in sensor technology, data analytics, and connectivity are key growth accelerators. Strategic partnerships between device manufacturers, healthcare providers, and pharmaceutical companies are fostering innovation and market expansion. Efforts to improve affordability and accessibility are driving market growth, particularly in underserved populations.
Key Players Shaping the North America Self-monitoring Blood Glucose Market Market
- Medisana
- Rossmax
- Trivida
- Platinum Equity (LifeScan)
- Acon
- Agamatrix Inc
- F. Hoffmann-La Roche AG
- Abbott
- Bionime Corporation
- Arkray
- Ascensia
Notable Milestones in North America Self-monitoring Blood Glucose Market Sector
- May 2023: LifeScan announced positive data from a real-world study supporting its Bluetooth-connected blood glucose meter, demonstrating sustained improvements in readings for over 55,000 people with diabetes. Results were published in Diabetes Therapy.
- January 2023: LifeScan announced publication in the Journal of Diabetes Science and Technology of real-world data from over 144,000 people with diabetes showing improved glycemic control using its Bluetooth-connected meter and mobile app.
In-Depth North America Self-monitoring Blood Glucose Market Market Outlook
The North American SMBG market is poised for continued growth, driven by technological advancements, expanding access to care, and a growing population with diabetes. Strategic partnerships and focus on user-friendly, data-driven solutions will shape future market dynamics. Opportunities abound for innovative companies to develop and deliver cutting-edge solutions that meet the evolving needs of individuals with diabetes. The market is expected to experience steady growth in the coming years, presenting significant opportunities for players to capitalize on.
North America Self-monitoring Blood Glucose Market Segmentation
-
1. Self-monitoring Blood Glucose Devices
-
1.1. By Component
- 1.1.1. Glucometer Devices
- 1.1.2. Lancets
-
1.1. By Component
-
2. Geography
- 2.1. United States
- 2.2. Canada
- 2.3. Rest of North America
North America Self-monitoring Blood Glucose Market Segmentation By Geography
- 1. United States
- 2. Canada
- 3. Rest of North America

North America Self-monitoring Blood Glucose Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.98% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Blood Glucose Test Strips Held the Largest Market Share in Current Year
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 5.1.1. By Component
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Lancets
- 5.1.1. By Component
- 5.2. Market Analysis, Insights and Forecast - by Geography
- 5.2.1. United States
- 5.2.2. Canada
- 5.2.3. Rest of North America
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. United States
- 5.3.2. Canada
- 5.3.3. Rest of North America
- 5.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 6. United States North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 6.1.1. By Component
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Lancets
- 6.1.1. By Component
- 6.2. Market Analysis, Insights and Forecast - by Geography
- 6.2.1. United States
- 6.2.2. Canada
- 6.2.3. Rest of North America
- 6.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 7. Canada North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 7.1.1. By Component
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Lancets
- 7.1.1. By Component
- 7.2. Market Analysis, Insights and Forecast - by Geography
- 7.2.1. United States
- 7.2.2. Canada
- 7.2.3. Rest of North America
- 7.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 8. Rest of North America North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 8.1.1. By Component
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Lancets
- 8.1.1. By Component
- 8.2. Market Analysis, Insights and Forecast - by Geography
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Rest of North America
- 8.1. Market Analysis, Insights and Forecast - by Self-monitoring Blood Glucose Devices
- 9. United States North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 10. Canada North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 11. Mexico North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 12. Rest of North America North America Self-monitoring Blood Glucose Market Analysis, Insights and Forecast, 2019-2031
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2024
- 13.2. Company Profiles
- 13.2.1 Medisana
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 Rossmax
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Trivida
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Platinum Equity (LifeScan)
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Acon
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Agamatrix Inc
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 F Hoffmann-La Roche AG
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Abbott
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Bionime Corporation
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.10 Arkray
- 13.2.10.1. Overview
- 13.2.10.2. Products
- 13.2.10.3. SWOT Analysis
- 13.2.10.4. Recent Developments
- 13.2.10.5. Financials (Based on Availability)
- 13.2.11 Ascensia
- 13.2.11.1. Overview
- 13.2.11.2. Products
- 13.2.11.3. SWOT Analysis
- 13.2.11.4. Recent Developments
- 13.2.11.5. Financials (Based on Availability)
- 13.2.1 Medisana
List of Figures
- Figure 1: North America Self-monitoring Blood Glucose Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: North America Self-monitoring Blood Glucose Market Share (%) by Company 2024
List of Tables
- Table 1: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 4: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 5: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 6: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Geography 2019 & 2032
- Table 7: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 9: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 10: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 11: United States North America Self-monitoring Blood Glucose Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United States North America Self-monitoring Blood Glucose Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 13: Canada North America Self-monitoring Blood Glucose Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Canada North America Self-monitoring Blood Glucose Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Mexico North America Self-monitoring Blood Glucose Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico North America Self-monitoring Blood Glucose Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Rest of North America North America Self-monitoring Blood Glucose Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Rest of North America North America Self-monitoring Blood Glucose Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 19: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 20: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 21: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 22: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Geography 2019 & 2032
- Table 23: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 24: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 25: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 26: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 27: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 28: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Geography 2019 & 2032
- Table 29: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 30: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 31: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 32: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Self-monitoring Blood Glucose Devices 2019 & 2032
- Table 33: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 34: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Geography 2019 & 2032
- Table 35: North America Self-monitoring Blood Glucose Market Revenue Million Forecast, by Country 2019 & 2032
- Table 36: North America Self-monitoring Blood Glucose Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Self-monitoring Blood Glucose Market?
The projected CAGR is approximately 6.98%.
2. Which companies are prominent players in the North America Self-monitoring Blood Glucose Market?
Key companies in the market include Medisana, Rossmax, Trivida, Platinum Equity (LifeScan), Acon, Agamatrix Inc, F Hoffmann-La Roche AG, Abbott, Bionime Corporation, Arkray, Ascensia.
3. What are the main segments of the North America Self-monitoring Blood Glucose Market?
The market segments include Self-monitoring Blood Glucose Devices, Geography.
4. Can you provide details about the market size?
The market size is estimated to be USD 8.10 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Blood Glucose Test Strips Held the Largest Market Share in Current Year.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
May 2023: LifeScan announced positive data from a study of real-world evidence supporting its Bluetooth-connected blood glucose meter. Evidence from more than 55,000 people with diabetes demonstrated sustained improvements in readings in range. The analysis focuses on changes over 180 days. LifeScan published results in the peer-reviewed journal Diabetes Therapy. The company’s OneTouch Bluetooth-connected blood glucose meter and mobile diabetes app provide simplicity, accuracy, and trust.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "North America Self-monitoring Blood Glucose Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the North America Self-monitoring Blood Glucose Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the North America Self-monitoring Blood Glucose Market?
To stay informed about further developments, trends, and reports in the North America Self-monitoring Blood Glucose Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence